Nucleic acid molecules encoding antibodies to a proliferation-inducing ligand (APRIL)
US10981982B2 · kind B2 · utility
1Cited by
8References
48Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 25, 2020 |
| Grant date | Apr 20, 2021 |
| Priority date | — |
| Expiry date | Jun 25, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibody molecules that specifically bind to APRIL are disclosed. The antibody molecules can be used to treat, prevent, and/or diagnose disorders, such as IgA nephropathy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.